Compare AMPH & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | ETON |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 872.7M |
| IPO Year | 2005 | 2018 |
| Metric | AMPH | ETON |
|---|---|---|
| Price | $21.02 | $33.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $28.38 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 614.0K | 334.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | 0.05 |
| Revenue | ★ $719,887,000.00 | $79,950,000.00 |
| Revenue This Year | $6.90 | $40.90 |
| Revenue Next Year | $4.64 | $47.23 |
| P/E Ratio | ★ $139.50 | $669.80 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $16.65 | $13.31 |
| 52 Week High | $31.26 | $35.66 |
| Indicator | AMPH | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 64.75 |
| Support Level | $18.92 | $15.77 |
| Resistance Level | $24.61 | $35.66 |
| Average True Range (ATR) | 0.83 | 1.64 |
| MACD | 0.11 | 0.18 |
| Stochastic Oscillator | 98.15 | 84.84 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.